Original ResearchLong-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
The PARTNER Trial was funded by Edwards Lifesciences.
Duke Clinical Research Institute and Columbia University Medical Center were the recipients of research grants from Edwards Lifesciences, Inc. Dr. Weissman has received grants from Edwards Lifesciences, Abbott Vascular, Medtronic, Sorin, Direct Flow Medical, Boston Scientific, and JenaValve. Dr. Hahn has received consultant fees from Edwards Lifesciences; and research support from Philips Healthcare. Dr. Pibarot holds the Canada research Chair in Valvular Heart Diseases, Canadian Institutes of Health Research, Ottawa, Ontario, Canada; and has received grant support from Edwards Lifesciences. Dr. Svensson holds equity in Cardiosolution and Valvexchange; and intellectual property with Postthorax. Dr. Kodali has received grants from Edwards Lifesciences and Medtronic; is a member of the PARTNER Trial Executive Committee; and holds equity in Thubrikar Aortic Valve, Inc. Dr. Szeto has received consulting fees/honoraria from Microinterventional Devices. Dr. Makkar has received grants from Edwards Lifesciences and St. Jude Medical; is a consultant for Abbott Vascular, Cordis, and Medtronic; and holds equity in Entourage Medical. Drs. Mack, Svensson, and Leon have received travel reimbursements from Edwards Lifesciences related to their work as unpaid members of the PARTNER Trial Executive Committee. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.